Kajalakshmy M, “Phase Ii Trial Of Bevacizumab, Irinotecan, And Cetuximab In Recurrent Glioblastoma Multiforme: Efficacy, Safety And Clinical Outcomes”, JRTDD, vol. 5, no. 2, pp. 788–792, Dec. 2022.